This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
May 1999
·
13 Reads
·
32 Citations
Cleveland Clinic Journal of Medicine
The United Kingdom Prospective Diabetes Study (UKPDS) showed that intensive treatment (i.e., glucose-lowering drugs, with a goal fasting blood glucose level of 108 mg/dL) decreases the microvascular complications of type 2 diabetes mellitus. We summarize the key study results and their implications for clinical management of type 2 diabetes mellitus.
April 1999
·
3 Reads
·
28 Citations
Cleveland Clinic Journal of Medicine
The United Kingdom Prospective Diabetes Study (UKPDS) showed that intensive treatment (ie, glucose-lowering drugs, with a goal fasting blood glucose level of 108 mg/dL) decreases the microvascular complications of type 2 diabetes mellitus. We summarize the key study results and their implications for clinical management of type 2 diabetes mellitus.
... Für das Auftreten eines diabetischen Makulaödems (DMÖ) ist neben der chronischen Hyperglykämie vor allem die arterielle Hypertonie ein signifikanter Risikofaktor [12]. ...
April 1999
Cleveland Clinic Journal of Medicine
... Diabetes kills over 5 million people every year, and most of them died of diabetic complications (3). Some studies including the UK Prospective Diabetes Study (UKPDS) and the Diabetes Control and Complications Trial (DCCT) have confirmed that good blood sugar control could effectively reduce the risk of diabetic complications (4,5). Thus, blood glucose monitoring has become essential for evaluating diabetic patients, developing a reasonable hypoglycemic regimen, reflecting the effectiveness of hypoglycemic treatment, and guiding treatment adjustment. ...
May 1999
Cleveland Clinic Journal of Medicine
